A study of aflibercept with or without initial photodynamic therapy for patients with polypoidal choroidal vasculopathy.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Aflibercept (Primary) ; Verteporfin (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 28 Aug 2017 New trial record